Patents by Inventor Anthony P. Davis

Anthony P. Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9937272
    Abstract: A water-soluble compound of the formula (I): wherein R9 and R10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: April 10, 2018
    Assignee: University of Bristol
    Inventors: Chenfeng Ke, Anthony P. Davis
  • Publication number: 20170266321
    Abstract: A water-soluble compound of the formula (I): wherein R9 and R10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.
    Type: Application
    Filed: February 28, 2017
    Publication date: September 21, 2017
    Applicant: University of Bristol
    Inventors: Chenfeng KE, Anthony P. Davis
  • Patent number: 9610365
    Abstract: A water-soluble compound of the formula (I): wherein R9 and R10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.
    Type: Grant
    Filed: April 26, 2013
    Date of Patent: April 4, 2017
    Assignee: University of Bristol
    Inventors: Chenfeng Ke, Anthony P. Davis
  • Publication number: 20150147275
    Abstract: A water-soluble compound of the formula (I): (Formula (I)) wherein R9 and R10 are suitably hydrophilic substituents, which may be used to selectively bind to a target saccharide such as glucose and which exhibits a detectable spectroscopic response to such binding, thus enabling its use in the detection and correction of blood glucose concentrations in vivo.
    Type: Application
    Filed: April 26, 2013
    Publication date: May 28, 2015
    Inventors: Chenfeng Ke, Anthony P. Davis